Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian Taylor Slingsby currently holds 8,644,579 shares of Mineralys Therapeutics, Inc. (MLYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Taylor Slingsby has been a net seller of MLYS stock. They have purchased $4.0M and sold $7.2M worth of shares.
Brian Taylor Slingsby's most recent insider trade was on Jul 24, 2024, when they sold 550,000 shares at $13.05 per share.
Brian Taylor Slingsby serves as Executive at Mineralys Therapeutics, Inc. (MLYS). They have executed 3 insider transactions totaling $11.2M over their tenure at the company.
Brian Taylor Slingsby holds the position of Executive at Mineralys Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Brian Taylor Slingsby has shown a selling trading pattern, with $4.0M in total purchases and $7.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brian Taylor Slingsby was on Jul 24, 2024, when they sold $7.2M worth of MLYS shares. This transaction involved 550,000 shares at $13.05 per share.
Brian Taylor Slingsby currently owns 8,644,579 shares of Mineralys Therapeutics, Inc. (MLYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian Taylor Slingsby's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian Taylor Slingsby has 3 Form 4 filings on record as an insider at Mineralys Therapeutics, Inc..
Set alerts for Brian Taylor Slingsby and 40,000+ other insiders.